These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3977673)

  • 1. Brightness-sense and optic nerve disease.
    Sadun AA; Lessell S
    Arch Ophthalmol; 1985 Jan; 103(1):39-43. PubMed ID: 3977673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing between clinical impairments due to optic nerve or macular disease.
    Sadun AA
    Metab Pediatr Syst Ophthalmol (1985); 1990; 13(2-4):79-84. PubMed ID: 2079911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of unilateral afferent pupillary defects by pupillography.
    Fison PN; Garlick DJ; Smith SE
    Br J Ophthalmol; 1979 Mar; 63(3):195-9. PubMed ID: 435432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of spatial frequency response by normal, recovered optic neuritis, and normal fellow eyes to a new linearly variable neutral density device.
    Haupt EJ; Katz R; Chin P; Cinotti AA; Frohman L
    Graefes Arch Clin Exp Ophthalmol; 1993 Feb; 231(2):79-83. PubMed ID: 8444363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brightness sensitivity and color perception as predictors of relative afferent pupillary defect.
    Danesh-Meyer HV; Papchenko TL; Savino PJ; Gamble GD
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3616-21. PubMed ID: 17652731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The simultaneous interocular brightness sense test. A test of optic nerve function.
    MacMillan ES; Cummins D; Heron G; Dutton GN
    Arch Ophthalmol; 1994 Sep; 112(9):1190-7. PubMed ID: 8085962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of brightness comparison testing in predicting afferent pupillary defects.
    Browning DJ; Buckley EG
    Arch Ophthalmol; 1988 Mar; 106(3):341-3. PubMed ID: 3345152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast visual testing in neurovisual diagnosis.
    Lorance RW; Kaufman D; Wray SH; Mao C
    Neurology; 1987 Jun; 37(6):923-9. PubMed ID: 3587642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-contrast letter charts to detect subtle optic [corrected] neuropathies.
    Drucker MD; Savino PJ; Sergott RC; Bosley TM; Schatz NJ; Kubilis PS
    Am J Ophthalmol; 1988 Feb; 105(2):141-5. PubMed ID: 3341430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial.
    Keltner JL; Johnson CA; Spurr JO; Beck RW
    Am J Ophthalmol; 1999 Nov; 128(5):543-53. PubMed ID: 10577521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual field versus visual evoked potentials in maculopathies and optic neuropathies.
    Wang Y; Wu DZ; Wu LZ; Chen YZ
    Yan Ke Xue Bao; 1989 Jun; 5(1-2):52-9. PubMed ID: 2485746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various stages of optic neuritis assessed by subjective brightness of flicker.
    Trauzettel-Klosinski S
    Arch Ophthalmol; 1989 Jan; 107(1):63-8. PubMed ID: 2910289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional threshold contrast sensitivity within the central visual field in optic neuritis.
    Plant GT; Hess RF
    Brain; 1987 Apr; 110 ( Pt 2)():489-515. PubMed ID: 3567533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual evoked potential and pupillary signs. A comparison in optic nerve disease.
    Cox TA; Thompson HS; Hayreh SS; Snyder JE
    Arch Ophthalmol; 1982 Oct; 100(10):1603-7. PubMed ID: 7138329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cup-disc ratio and ischemic optic neuropathy.
    Doro S; Lessell S
    Arch Ophthalmol; 1985 Aug; 103(8):1143-4. PubMed ID: 4026643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brightness-sense comparison in patients with optic nerve hypoplasia.
    Zeki SM
    Acta Ophthalmol (Copenh); 1991 Oct; 69(5):649-53. PubMed ID: 1776421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
    Li XJ; Tong Y; Zhang SK
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1060-4. PubMed ID: 23336407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Aulhorn flicker test. I: Concomitant neuritis in malignant non-Hodgkin's lymphoma and leukodystrophy].
    Pittke EC; Thill-Schwaninger M
    Klin Monbl Augenheilkd; 1988 Aug; 193(2):157-64. PubMed ID: 3184749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripapillary nerve fiber layer thickness measured by optical coherence tomography in patients with no light perception from long-standing nonglaucomatous optic neuropathies.
    Chan CK; Miller NR
    J Neuroophthalmol; 2007 Sep; 27(3):176-9. PubMed ID: 17895816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.
    Arch Ophthalmol; 1991 Dec; 109(12):1673-8. PubMed ID: 1841573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.